Max India Limited
NSE: MAXIND
Prev Close
214.81
Open Price
215.01
Volume
62,852
Today Low / High
212 / 222
52 WK Low / High
169 / 320.69
Range
209 - 230
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 219.5, with a change of 4.69 (2.18332%). The expected target range on the NSE is between 209 - 230. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
Max India Limited Graph
Max India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Max India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 219.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 219.50 | 221.70 | 199.53 - 243.86 |
| 223.89 | 179.11 - 268.67 | ||
| 226.09 | 158.26 - 293.91 | ||
| Bearish Scenario | 219.50 | 217.31 | 195.57 - 239.04 |
| 215.11 | 172.09 - 258.13 | ||
| 212.92 | 149.04 - 276.79 |
Overview of Max India Limited
ISIN
INE0CG601016
Industry
Medical - Care Facilities
Vol.Avg
93,865
Market Cap
11,456,868,350
Last Dividend
0
Official Website
IPO Date
2020-08-28
DCF Diff
432.76
DCF
-213
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 145.49 Cr | 148.11 Cr | -2.62 Cr | -0.0180 | 0.00 Cr | 24.92 Cr | -137.35 Cr | -140.39 Cr | -32.52 | -112.45 Cr | -0.9649 |
| 2024-03-31 | 157.80 Cr | 63.53 Cr | 94.27 Cr | 0.5974 | 0.00 Cr | 22.53 Cr | -64.20 Cr | -56.38 Cr | -13.08 | -37.64 Cr | -0.3573 |
| 2023-03-31 | 201.03 Cr | 83.72 Cr | 117.31 Cr | 0.5835 | 0.00 Cr | 17.24 Cr | 3.21 Cr | -10.40 Cr | -2.19 | 11.66 Cr | -0.0517 |
| 2022-03-31 | 169.06 Cr | 129.04 Cr | 40.02 Cr | 0.2367 | 0.00 Cr | 14.89 Cr | -10.23 Cr | -18.04 Cr | -3.35 | -3.89 Cr | -0.1067 |
| 2021-03-31 | 93.26 Cr | 17.47 Cr | 75.79 Cr | 0.8127 | 0.00 Cr | 21.47 Cr | -54.10 Cr | -53.12 Cr | -9.88 | -30.03 Cr | -0.5696 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 109.53 Cr | 632.85 Cr | 274.16 Cr | 358.6900 Cr | 102.30 Cr | -7.23 Cr | 16.64 Cr | 173.82 Cr | 0.00 Cr | 0.00 Cr | 81.69 Cr | 165.2500 Cr |
| 2024-03-31 | 116.03 Cr | 684.34 Cr | 192.00 Cr | 492.3433 Cr | 43.57 Cr | -72.47 Cr | 6.13 Cr | 121.77 Cr | 0.59 Cr | 0.00 Cr | 102.75 Cr | 138.8384 Cr |
| 2023-03-31 | 88.73 Cr | 753.40 Cr | 211.30 Cr | 542.1000 Cr | 45.30 Cr | -43.43 Cr | 51.01 Cr | 90.66 Cr | 95.43 Cr | 0.00 Cr | -273.48 Cr | 161.4800 Cr |
| 2022-03-31 | 28.92 Cr | 854.04 Cr | 216.95 Cr | 637.0983 Cr | 60.76 Cr | 31.84 Cr | 130.36 Cr | 85.49 Cr | 136.36 Cr | 0.00 Cr | -350.94 Cr | 153.1862 Cr |
| 2021-03-31 | 24.11 Cr | 997.61 Cr | 344.41 Cr | 653.1970 Cr | 144.84 Cr | 120.73 Cr | 249.37 Cr | 89.53 Cr | 161.45 Cr | 0.00 Cr | -401.11 Cr | 225.8877 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -111.5511 Cr | 30.6300 Cr | -12.4128 Cr | -147.4300 Cr | -93.3352 Cr | 22.7000 Cr | -35.8800 Cr | -140.3900 Cr | 0.2400 Cr | 0.0000 Cr | -10.5100 Cr |
| 2024-03-31 | -102.3440 Cr | 158.6438 Cr | -28.9960 Cr | -131.0952 Cr | 27.3039 Cr | 116.0305 Cr | -28.7512 Cr | -49.0511 Cr | -21.2284 Cr | 0.0000 Cr | 44.8900 Cr |
| 2023-03-31 | 69.4100 Cr | 124.0800 Cr | -118.5400 Cr | 65.7500 Cr | 74.9500 Cr | 88.7300 Cr | -3.6600 Cr | -3.0200 Cr | -17.9499 Cr | 0.0000 Cr | 79.3500 Cr |
| 2022-03-31 | 66.4958 Cr | 32.2506 Cr | -93.9414 Cr | 59.7961 Cr | 4.8051 Cr | 28.9180 Cr | -6.6997 Cr | -14.7991 Cr | -81.7905 Cr | 0.0000 Cr | 119.0120 Cr |
| 2021-03-31 | 72.6671 Cr | 12.5227 Cr | -73.3099 Cr | 60.9157 Cr | 11.8799 Cr | 24.1129 Cr | -11.7514 Cr | -55.5252 Cr | -48.1533 Cr | 0.0000 Cr | -23.2542 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 36.67 Cr | 8.75 Cr | 27.92 Cr | 0.7614 | -33.62 Cr | -25.64 Cr | -5.44 | -15.37 Cr | -0.6992 |
| 2025-03-31 | 41.52 Cr | 45.45 Cr | -3.93 Cr | -0.0947 | -45.05 Cr | -46.09 Cr | -10.68 | -35.85 Cr | -1.1101 |
| 2024-12-31 | 34.74 Cr | 9.76 Cr | 24.98 Cr | 0.7191 | -34.67 Cr | -44.60 Cr | -10.33 | -37.34 Cr | -1.2838 |
| 2024-09-30 | 42.77 Cr | 32.68 Cr | 10.09 Cr | 0.2359 | -25.76 Cr | -22.73 Cr | -5.27 | -15.69 Cr | -0.5314 |
| 2024-06-30 | 26.46 Cr | 31.19 Cr | -4.73 Cr | -0.1788 | -31.87 Cr | -26.97 Cr | -6.25 | -22.28 Cr | -1.0193 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 109.53 Cr | 33.72 Cr | 143.25 Cr | 22.36 Cr | 16.64 Cr | 260.54 Cr | 173.82 Cr | 632.85 Cr | 274.16 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 248.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -444.82 Cr |
| 2024-09-30 | 66.72 Cr | 181.82 Cr | 248.54 Cr | 0.14 Cr | 9.69 Cr | 298.57 Cr | 147.85 Cr | 658.05 Cr | 213.23 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 300.00 Cr | 0.00 Cr | 0.00 Cr | 300.00 Cr | 0.00 Cr | 0.00 Cr | -492.34 Cr |
| 2024-03-31 | 209.02 Cr | 51.73 Cr | 260.75 Cr | 5.32 Cr | 6.13 Cr | 343.25 Cr | 121.77 Cr | 684.34 Cr | 192.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -44.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -22.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -26.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -21.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -17.90 Cr | 4.86 Cr | 0.00 Cr | 0.00 Cr | 4.86 Cr | 170.27 Cr | 165.41 Cr | 0.00 Cr | 4.86 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2025-04-29 | April 29, 25 | 529:500 |
| 2022-07-26 | July 26, 22 | 4:5 |
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,234.70 | ₹1,200,371,493,910.00 | ₹1,487,935.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,922.50 | ₹1,139,136,662,500.00 | ₹843,635.00 |
| Fortis Healthcare Limited | FORTIS | ₹934.40 | ₹705,432,755,200.00 | ₹1,777,868.00 |
| Global Health Limited | MEDANTA | ₹1,384.70 | ₹372,041,749,880.00 | ₹243,552.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,813.70 | ₹370,649,545,700.00 | ₹137,642.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹602.50 | ₹312,167,902,500.00 | ₹919,644.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹736.80 | ₹294,822,415,200.00 | ₹188,342.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,577.40 | ₹160,187,610,568.00 | ₹38,800.00 |
| HealthCare Global Enterprises Limited | HCG | ₹677.70 | ₹94,481,545,500.00 | ₹76,902.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹716.15 | ₹69,004,171,333.00 | ₹283,413.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹459.50 | ₹42,123,743,500.00 | ₹140,362.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹238.02 | ₹33,060,978,000.00 | ₹68,033.00 |
Key Executives
Gender: male
Year Born: 1978
Gender: Not Specified
Year Born: 1974
Gender: female
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1980
Gender: female
Year Born: 1981
Gender: male
Year Born: 1954
Gender: male
Year Born: 1962
FAQs about Max India Limited
The CEO is Analjit Singh BA, BS, MBA.
The current price is ₹219.50.
The range is ₹169-320.69.
The market capitalization is ₹1,145.69 crores.
The P/E ratio is -7.44.
The company operates in the Healthcare sector.
Overview of Max India Limited (ISIN: INE0CG601016) is a leading Medical - Care Facilities in India. With a market capitalization of ₹1,145.69 crores and an average daily volume of 93,865 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.